Bionime (TPE:4737) FCF Margin % : -26.63% (As of Jun. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Bionime FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bionime's Free Cash Flow for the three months ended in Jun. 2024 was NT$-126 Mil. Bionime's Revenue for the three months ended in Jun. 2024 was NT$475 Mil. Therefore, Bionime's FCF Margin % for the quarter that ended in Jun. 2024 was -26.63%.

As of today, Bionime's current FCF Yield % is -7.29%.

The historical rank and industry rank for Bionime's FCF Margin % or its related term are showing as below:

TPE:4737' s FCF Margin % Range Over the Past 10 Years
Min: -16.59 Med: -1.57 Max: 24.19
Current: -16.59

During the past 13 years, the highest FCF Margin % of Bionime was 24.19%. The lowest was -16.59%. And the median was -1.57%.

TPE:4737's FCF Margin % is ranked worse than
59.06% of 828 companies
in the Medical Devices & Instruments industry
Industry Median: -6.405 vs TPE:4737: -16.59

Bionime FCF Margin % Historical Data

The historical data trend for Bionime's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionime FCF Margin % Chart

Bionime Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

12.31

-4.72

-0.80

-7.72

-13.55

Bionime Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
FCF Margin %	Get a 7-Day Free Trial															-28.99	-18.50	-17.00	-4.25	-26.63

Competitive Comparison of Bionime's FCF Margin %

For the Medical Instruments & Supplies subindustry, Bionime's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionime's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bionime's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bionime's FCF Margin % falls into.

Bionime FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bionime's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-237.954	/	1755.567
	=	-13.55 %

Bionime's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-126.424	/	474.785
	=	-26.63 %

Bionime FCF Margin % Related Terms

Thank you for viewing the detailed overview of Bionime's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionime Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bionime Corp (TPE:4737) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 100, Daqing Street, Section 2, South District, Taichung, TWN, 40242

Website

https://www.bionime.com

Bionime Corp is engaged in the business of biotechnology and medical testing in Taiwan. The company's products include blood glucose monitoring devices, Lancing device, Testing Strips, and blood glucose testing chips which are applied in the testing and monitoring of blood glucose density.

Bionime Headlines

No Headlines